The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of trastuzumab-pkrb and docetaxel anhydrous combination therapy in recurrent or metastatic salivary ductal carcinomas (KCSG HN18-08/KM11).
 
Jiyun Lee
No Relationships to Disclose
 
Sehhoon Park
Stock and Other Ownership Interests - Lunit
 
Hyun Ae Jung
No Relationships to Disclose
 
Se-Hoon Lee
Honoraria - AstraZeneca/MedImmune; Merck; Roche
Consulting or Advisory Role - AstraZeneca; Merck; Pfizer; Roche
Research Funding - Merck
Travel, Accommodations, Expenses - Novartis
 
Seyoung Seo
No Relationships to Disclose
 
Sung-Bae Kim
Stock and Other Ownership Interests - Neogene TC Corp, Genopeak; Neogene TC Corp, Genopeak
Honoraria - DAEHWA Pharmaceutical; ISU ABXIS
Consulting or Advisory Role - AstraZeneca; BeiGene; DAEHWA Pharmaceutical; Daiichi Sankyo/Astra Zeneca; ISU Abxis; Lilly (Inst)
Research Funding - Dongkook Pharma (Inst); Genzyme (Inst); Novartis (Inst)
 
Ji-Won Kim
Leadership - Genealogy Care
 
Keun Wook Lee
No Relationships to Disclose
 
Eun Joo Kang
No Relationships to Disclose
 
Ju Won Kim
No Relationships to Disclose
 
Yoon Ji Choi
No Relationships to Disclose
 
Byoung Yong Shim
Consulting or Advisory Role - Takeda
Research Funding - Yuhan
 
Ho Jung An
No Relationships to Disclose
 
Lee Chun Park
No Relationships to Disclose
 
SeongHoon Shin
No Relationships to Disclose
 
Jae-Joon Kim
No Relationships to Disclose
 
So Yeon Oh
No Relationships to Disclose
 
Min Kyoung Kim
No Relationships to Disclose
 
Myung-Ju Ahn
Honoraria - Amgen; AstraZeneca; Lilly; Merck Serono; MSD; TAKEDA; YUHAN
Consulting or Advisory Role - Alpha pharmaceutical; Amgen; AstraZeneca; Lilly; Merck Serono; MSD; Pfizer; TAKEDA; YUHAN
Research Funding - YUHAN